In the pharmaceutical industry, successful dealmaking is about collaboration and creating long-term value. Deals are structured to combine the strengths of both parties to ensure a successful outcome, such as licensing or platform development. Key elements include assembling diverse deal teams with technical and financial expertise, aligning interests with stakeholders, and being culturally sensitive. The deal process involves in-depth due diligence, balancing risk and reward, and effective post-signing implementation. Successful deals share risks and rewards equitably, ensuring both parties benefit.

Join for free to read